Trial Profile
A Phase II Trial of Poly ICLC in Patients With Recurrent Anaplastic Glioma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Aug 2018
Price :
$35
*
At a glance
- Drugs Poly ICLC (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 11 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 25 May 2012 Additional lead trial centres identified as reported by ClinicalTrials.gov.
- 25 May 2012 Planned end date (Mar 2014) added as reported by ClinicalTrials.gov.